Artículos por temáticas

Applications of nanobodies in brain diseases

Zheng F, Pang Y, Li L, Pang Y, Zhang J, Wang X, Raes G.

Front Immunol. 2022 Nov 8;13:978513. doi: 10.3389/fimmu.2022.978513. eCollection 2022.

The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease

Wiatrak B, Balon K, Jawień P, Bednarz D, Jęśkowiak I, Szeląg A.

Int J Mol Sci. 2022 Apr 27;23(9):4862. doi: 10.3390/ijms23094862.

Polypharmacy in Older Adults with Alzheimer's Disease

Esumi S, Ushio S, Zamami Y.

Medicina (Kaunas). 2022 Oct 13;58(10):1445. doi: 10.3390/medicina58101445.

Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention

Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X.

Ageing Res Rev. 2022 Feb;74:101544. doi: 10.1016/j.arr.2021.101544. Epub 2021 Dec 18.

Toward noninvasive brain stimulation 2.0 in Alzheimer's disease

Menardi A, Rossi S, Koch G, Hampel H, Vergallo A, Nitsche MA, Stern Y, Borroni B, Cappa SF, Cotelli M, Ruffini G, El-Fakhri G, Rossini PM, Dickerson B, Antal A, Babiloni C, Lefaucheur JP, Dubois B, De

Ageing Res Rev. 2022 Mar;75:101555. doi: 10.1016/j.arr.2021.101555. Epub 2021 Dec 30.

Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials

Mortby ME, Adler L, Agüera-Ortiz L, Bateman DR, Brodaty H, Cantillon M, Geda YE, Ismail Z, Lanctôt KL, Marshall GA, Padala PR, Politis A, Rosenberg PB, Siarkos K, Sultzer DL, Theleritis C; ISTAART NPS

Am J Geriatr Psychiatry. 2022 Feb;30(2):119-147. doi: 10.1016/j.jagp.2021.06.016. Epub 2021 Jul 1.

Alzheimer's Disease: Treatment Strategies and Their Limitations

Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E.

Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954.

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajago

J Prev Alzheimers Dis. 2022;9(2):197-210. doi: 10.14283/jpad.2022.30.

ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies

Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC.

Mol Neurodegener. 2022 Nov 8;17(1):72. doi: 10.1186/s13024-022-00574-4.

Animal models of Alzheimer's disease: Applications, evaluation, and perspectives

Chen ZY, Zhang Y.

Zool Res. 2022 Nov 18;43(6):1026-1040. doi: 10.24272/j.issn.2095-8137.2022.289.

Diet in the Prevention of Alzheimer's Disease: Current Knowledge and Future Research Requirements

Stefaniak O, Dobrzyńska M, Drzymała-Czyż S, Przysławski J.

Nutrients. 2022 Oct 30;14(21):4564. doi: 10.3390/nu14214564.

Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials

Ossenkoppele R, van der Kant R, Hansson O.

Lancet Neurol. 2022 Aug;21(8):726-734. doi: 10.1016/S1474-4422(22)00168-5. Epub 2022 May 25.

The promise of music therapy for Alzheimer's disease: A review

Matziorinis AM, Koelsch S.

Ann N Y Acad Sci. 2022 Oct;1516(1):11-17. doi: 10.1111/nyas.14864. Epub 2022 Jul 18.

Physical activity as a protective factor for dementia and Alzheimer's disease: systematic review, meta-analysis and quality assessment of cohort and case-control studies

Iso-Markku P, Kujala UM, Knittle K, Polet J, Vuoksimaa E, Waller K.

Br J Sports Med. 2022 Jun;56(12):701-709. doi: 10.1136/bjsports-2021-104981. Epub 2022 Mar 17.

Alzheimer disease and neuroplasticity

Koch G, Spampinato D.

Handb Clin Neurol. 2022;184:473-479. doi: 10.1016/B978-0-12-819410-2.00027-8.